Skip to main content

Department of Pharmacology

A probiotic treatment for obesity?

Aug. 8, 2019—Engineered bacteria that produce beneficial compounds — and that could potentially be administered in foods like yogurt — may be a future treatment for obesity and other chronic diseases.

Read more


Defective transporter linked to autism

Jul. 24, 2019—A first-of-its-kind mouse model may help reveal mechanistic underpinnings for the altered behaviors of autism spectrum disorder.

Read more


Potassium balance and glaucoma

Jul. 15, 2019—Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.

Read more


Yohn named Postdoc of the Year at annual symposium; Sappington named Mentor of the Year

Apr. 22, 2019—Postdoctoral scholars Samantha Yohn and Anneke Sanders and ophthalmology professor Rebecca Sappington were honored by the Graduate School at the 13th Annual Vanderbilt Postdoctoral Association Symposium on April 9.

Read more


The arrestin-GPCR connection

Apr. 12, 2019—Vsevolod Gurevich and colleagues have discovered new insights into arrestin proteins, which turn off a cell's environmental message "inbox."

Read more


Reprogramming cells for kidney repair

Mar. 14, 2019—Lauren Woodard and Matthew Wilson have discovered a way to reprogram adult human kidney cells into cells similar to those that form during embryonic development, which could lead to new kidney disease treatments.

Read more


New way to stimulate learning?

Mar. 14, 2019—Stimulating the vagus nerve triggers certain epigenetic changes involving learning and memory.

Read more


Vanderbilt scientists report new modeling of brain signaling

Mar. 7, 2019—Heidi Hamm and colleagues have reported the first animal model of a "shut-off valve" for neurotransmitter and hormone release through SNARE complex-mediated membrane fusion.

Read more


Gene identified that increases risk of antibiotic reaction

Feb. 28, 2019—Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.

Read more


Modulating stress circuits

Feb. 15, 2019—Danny Winder and colleagues have demonstrated how norepinephrine and a stress factor call CRF interact, which may lead to new treatments for stress-related disorders.

Read more


Lindsley named fellow of National Academy of Inventors

Jan. 4, 2019—Craig Lindsley, co-director of the┬áVanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the┬áNational Academy of Inventors.

Read more


Cytokine-cognition connection

Oct. 4, 2018—Erin Calipari and colleagues have shown that peripheral administration of a neuroprotective cytokine may improve dopamine signaling problems associated with certain psychiatric disorders.

Read more


VIEW MORE EVENTS >